Hydrogen Europe Appoints New Board Members to Accelerate Deployment of Hydrogen Technologies in Europe
DRESDEN, Germany, 2016-07-01 09:00 CEST (GLOBE NEWSWIRE) --
FuelCell Energy Solutions, GmbH (FCES), a provider of ultra-clean, efficient and reliable stationary fuel cell power plants, announced the appointment of Andreas Froemmel, Vice President of Business and Commercial Development at FCES, to Vice-Chair of Hydrogen Europe (formerly New Energy World - Industry Group or NEW-IG); a leading industry association comprised of about 100 companies dedicated to advancing the deployment of hydrogen and fuel cell technologies in Europe. As Vice-Chair, Froemmel will work closely with newly appointed Board Chairman Raphaël Schoentgen of ENGIE, the French multinational utility company, to craft and execute the Hydrogen Europe initiatives.
“The Hydrogen Europe association is dedicated to developing awareness, markets, policy and regulatory framework to enable hydrogen deployment in Europe,” said newly appointed Vice-Chair Andreas Froemmel. “It represents the collaborative effort between industry, utilities and government to advance the integration of the hydrogen society.”
“Industry leaders working cooperatively and closely with regulatory and government officials, such as Hydrogen Europe is doing, illustrates the value of public/private partnerships for showcasing the many advantages of greater hydrogen adoption for clean and affordable power and transportation,” said Chip Bottone, President and Chief Executive Officer FuelCell Energy, Inc. and Managing Director, FuelCell Energy Solutions, GmbH. “The FuelCell Energy Solutions team is pleased to be part of the solution for achieving the energy and environmental goals of Europe.”
The Hydrogen Europe Board of Directors is comprised of executives from leading European companies including Dr. Katharina Beumelburg, Executive Vice-President Hydrogen Solutions, Siemens; Didier Pfleger, Senior Vice President, Alstom; Valérie Bouillon-Delporte, New Business Opportunities Director, Michelin; and Thomas Melczer, Director of Business Development, Proton Motor.
Hydrogen Europe’s mission is to enhance environmental and economic sustainability while positioning Europe at the forefront of global energy-related technological developments. It is the industry partner of the European Commission and the Research community (N.ERGHY) within the Fuel Cells and Hydrogen Joint Undertaking (FCH JU); this unique public-private partnership with N.ERGHY within the FCH JU supports Europe’s development and commercial introduction of clean technologies in the transport and energy sectors.
Mr. Froemmel’s leadership at FCES, since the company’s founding in 2012, has directly impacted the market awareness of affordable and ultra-clean stationary fuel cell power plants in Europe; implementing installations in Berlin with the German Government and in London, including a downtown office tower, 20 Fenchurch, and the Crown Estate owned Regent Street development as well as the execution of a project development agreement with EON Connecting Energies. Mr. Froemmel actively engages with European and German legislative and regulatory officials to advocate the whole fuel cell and hydrogen sector with a special focus on stationary fuel cell power plants at the confluence of energy, environmental and economic policies.
About Hydrogen Europe
Hydrogen Europe (formerly known as NEW-IG) is the leading industry association working to make hydrogen energy an everyday reality in Europe. The group represents almost 100 companies, both large and SMEs, and partners with the European Commission and the research community in a public-private partnership, Fuel Cells and Hydrogen Joint Undertaking, worth €1.3 billion to accelerate the market introduction of these clean technologies in energy and transport. It also serves as the industry’s reference point and key advocate towards European decision-makers. Learn more about Hydrogen Europe at http://hydrogeneurope.eu/
About FuelCell Energy Solutions, GmbH
FuelCell Energy Solutions manufactures, sells, installs, and services stationary fuel cell power plants that efficiently and economically generate electricity and usable high quality heat suitable for making steam. Administrative offices are located in Dresden, Germany and manufacturing operations are located in Taufkirchen, Germany. Continuous power generated at the point of use with the virtual absence of pollutants supports energy security and power reliability as well as sustainability initiatives. Ultra-Clean baseload distributed generation is attractive to electric utilities, universities, hospitals, government facilities, industrial operations and other locations with significant power needs. For more information please visit www.fces.de.
Direct FuelCell, DFC, DFC/T, DFC-H2, DFC-ERG and FuelCell Energy logo are all registered trademarks in the U.S.A. of FuelCell Energy, Inc.
FuelCell Energy Solutions GmbH
+ 49 351 2553 7397
FuelCell Energy, Inc.
Vice President Investor Relations
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
Concurrent Achieves Sales Milestone for Zephyr Transcode19.10.2017 15:35 | Pressemelding
Concurrent Customers Now Transcoding on Three Continents ATLANTA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Concurrent (NASDAQ:CCUR), a global leader in storage, protection, transformation, and delivery of visual media assets, announced today that Zephyr Transcode, which Concurrent launched last year as an integral part of its content delivery network (CDN) solutions, is now deployed with customers in Asia, Europe and North America. The deployments already support thousands of on-demand assets being transcoded to multiple formats and bit-rates to support any place, any device content availability. Zephyr Transcode supports multiple formats and quality levels including H.264 (MPEG-4) and H.265 (HEVC), strengthening Concurrent customers' capability to provide high-quality standards-based streams to any device their end-users desire. Zephyr Transcode is software-based and capable of running in traditional Central Processing Units (CPU) as well as Gra
German Armed Forces Renews Contract for Hexagon Geospatial Products19.10.2017 15:11 | Pressemelding
Defense agency will work closely with Hexagon Geospatial Premium Partner for next two years NORCROSS, Ga., Oct. 19, 2017 (GLOBE NEWSWIRE) -- At the HxGN LOCAL Defense Summit, a conference dedicated to defense and security in Western Europe, Hexagon Geospatial announced that the Bundeswehr Geoinformation Centre (BGIC) recently renewed a large software maintenance contract for Hexagon Geospatial products. The two-year renewal is for more than 100 licenses, mainly within the GeoMedia and ImageStation product families. The contract also includes consulting for workflow optimization. The contract was issued to Geosystems, a Hexagon Geospatial Premium Partner, which will work closely with the local subsidiary of Hexagon Safety & Infrastructure in Bonn and Munich to support BGIC. "The strong Hexagon Geospatial partner network allows our defense customers to benefit from a unique pool of expertise and tradecraft in the areas of remote sensing, GIS, and photog
Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience19.10.2017 14:00 | Pressemelding
SANTA CLARA, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces a live webinar to be presented by Dr. Michelle Mack, Director of Global Scientific Engagement, entitled "Beyond Syngeneics - Novel Tools for Addressing Human Specificity in Immuno-Oncology." Checkpoint inhibitors like anti-PD-1, anti-PD-L1, and anti-CTLA-4 have revolutionized cancer treatment and have recently gained approval in several cancer types. Despite their potential, immunotherapies face significant development challenges due to the specificity and complexity of the human immune system upon which they act. Crown Bioscience has generated innovative research models to address these obstacles early during preclinical drug development.
Perfectus Aluminum Inc. Responds to Trade Group19.10.2017 13:00 | Pressemelding
ONTARIO, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Perfectus Aluminum Inc. has issued the following: On October 12, 2017 the Aluminum Extruders Council (AEC), an industry group representing largely American aluminum extruders, posted to its blog a false narrative regarding a suit to which Perfectus Aluminum Inc. is a related party. The government is not "seeking unpaid duties from Perfectus for goods brought into the country." Rather, the government is attempting to use a 2017 Department of Commerce determination to assess retroactive antidumping duties on goods imported as early as 2011. It is discouraging that AEC would tout such an obviously egregious government overstep as a "victory" to their members and the industry: were it one of AEC's own members facing such an obvious violation of fair play and due process, it would rightfully argue that government overreach is a threat to manufacturers everywhere. In addition to the hypocrisy of the AEC's promotion of this case, its s
Payvision's annual report reveals cross-border ecommerce trends in 201719.10.2017 09:00 | Pressemelding
With online marketplaces and consumer technology leading the way for growth AMSTERDAM, The Netherlands, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Payvision, global acquirer and data-driven omnichannel solutions provider, has published the findings of its fifth annual cross-border ecommerce research report, in collaboration with Juniper Research. The paper includes the results of a global survey of various industry players regarding the game-changers, the biggest challenges, the best practices for going cross-border, and much more. When compared to last year's findings, the report reveals a new and exciting context for global cross-border trade. The compound annual growth rate predicted for the next three years for cross-border ecommerce is now 17%, whereas it stands at just 12% for ecommerce overall. Also, over the past 12 months, merchants' attitudes towards cross-border ecommerce have become more positive, with 50% of respondents agreeing and 31% strongly
High Seizure Frequency in Children with Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds19.10.2017 08:00 | Pressemelding
Global survey of 584 caregivers of children, young adults and adults with Dravet illustrates the detrimental effect of debilitating, frequent seizures on quality of life and co-morbidities Results suggest a need for more effective antiepileptic treatments EMERYVILLE, Calif. and BREST, France, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Dravet Syndrome European Federation and Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, announced today the publication of the initial results from a landmark survey into the clinical, social and economic consequences of Dravet syndrome on children, young adults and their families in Developmental Medicine & Child Neurology [doi:10.1111/dmcn.13591]. This study was led by Lieven Lagae, M.D., Ph.D., Professor at the University of Leuven, Belgium, Head of the Pediatric Neurology Department and Director of the Childhood Epilepsy
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom